RNA editing is the next frontier in gene therapy – here’s what you need to know
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. This trial marks a new (...)
Site référencé: Raw Story
Raw Story
Trump dealt a legal blow from his own appointee : 'Neither reasoned nor rational'
12/08/2025
‘Major step’ : Ex-official warns Trump just moved closer to dark goal ‘he’s always wanted’
12/08/2025
Zuckerbergs’ ‘pandemic pod’ school forced to close after neighbor backlash
12/08/2025
'Panic rippling' : Coffee exec warns 'things are getting very dark' under Trump
12/08/2025
'What gives you the right ?' CNN's Jake Tapper calls out Texas gov on GOP’s election scheme
12/08/2025
Harvard braces for massive financial blow as truce nears with Trump
12/08/2025
